Blue Jet Healthcare Limited (BOM:544009)
India · Delayed Price · Currency is INR 356.85
+5.85 (1.67%)
At close: Apr 2, 2026
Blue Jet Healthcare Revenue
Blue Jet Healthcare had revenue of 1.92B INR in the quarter ending December 31, 2025, a decrease of -39.57%. This brings the company's revenue in the last twelve months to 10.53B, up 20.56% year-over-year. In the fiscal year ending March 31, 2025, Blue Jet Healthcare had annual revenue of 10.30B with 44.74% growth.
Revenue (ttm)
10.53B
Revenue Growth
+20.56%
P/S Ratio
5.89
Revenue / Employee
53.73M
Employees
196
Market Cap
61.99B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 10.30B | 3.18B | 44.74% |
| Mar 31, 2024 | 7.12B | -93.84M | -1.30% |
| Mar 31, 2023 | 7.21B | 375.13M | 5.49% |
| Mar 31, 2022 | 6.83B | 1.85B | 36.99% |
| Mar 31, 2021 | 4.99B | -392.63M | -7.30% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jubilant Pharmova | 79.18B |
| Granules India | 50.92B |
| Caplin Point Laboratories | 20.92B |
| FDC Limited | 20.78B |
| Sanofi India | 19.33B |
| Viyash Scientific | 18.17B |
| Rubicon Research | 15.98B |
| Procter & Gamble Health | 13.49B |